Ligand Pharmaceuticals (LGND) Net Equity Issued and Repurchased (2010 - 2024)
Ligand Pharmaceuticals (LGND) posted Net Equity Issued and Repurchased of $3.1 million for Q4 2024, up 156.55% sequentially from -$5.5 million in Q4 2013.
Ligand Pharmaceuticals (LGND) Net Equity Issued and Repurchased (2010 - 2024) Analysis & Trends
Ligand Pharmaceuticals has reported Net Equity Issued and Repurchased for 5 years, with the latest figure at $3.1 million in Q4 2024.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $3.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$2.4 million (down 3050.62% YoY) and the FY2024 annual result came in at $37.1 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased advanced to $3.1 million in Q4 2024 per LGND's latest filing, from -$5.5 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $3.1 million in Q4 2024 and troughed at $3.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.11 Mn |
| Dec 31, 2024 | 3.11 Mn |
| Dec 31, 2013 | -5.50 Mn |
| Dec 31, 2013 | -5.50 Mn |
| Dec 31, 2012 | 2.47 Mn |
| Dec 31, 2012 | 2.47 Mn |
| Sep 30, 2012 | 2.60 Mn |
| Sep 30, 2012 | 2.60 Mn |
| Jun 30, 2012 | 82,000.00 |
| Jun 30, 2012 | 82,000.00 |
| Mar 31, 2012 | 160,000.00 |
| Mar 31, 2012 | 160,000.00 |
| Dec 31, 2011 | -2,000.00 |
| Dec 31, 2011 | -2,000.00 |
| Sep 30, 2011 | 2,000.00 |
| Sep 30, 2011 | 2,000.00 |
| Dec 31, 2010 | -87,000.00 |
| Dec 31, 2010 | -87,000.00 |
| Sep 30, 2010 | -2,000.00 |
| Sep 30, 2010 | -2,000.00 |